Home » Topics » BioWorld Science

BioWorld Science
RSS

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

Nov. 11, 2021

TQS-168 extends survival in mouse model of ALS

Nov. 11, 2021

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

Nov. 11, 2021

XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors

Nov. 11, 2021

New GnRH-R antagonists identified at Shanghai Innofortune Biotech

Nov. 11, 2021

SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors

Nov. 11, 2021

PharmaBlock Sciences discovers p300 and CREBBP inhibitors

Nov. 11, 2021

New NMDA receptor antagonists described by Suzhou Nhwa Biomedical Technology

Nov. 11, 2021

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

Nov. 11, 2021

UBE-1099: a novel Keap1-Nrf2 PPI inhibitor for kidney disease

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...